62 research outputs found
PHP71 Differential Pricing For Pharmaceuticals: Overview Of A Widely Debated Pricing Concept And Key Challenges
PMH31 Public Beliefs and Attitudes about Schizophrenia, Major Depression and Psychotropic Medication in Tunisia
PSY111 Orphan Drug Regulation In The Usa, European Union, Japan and South Korea: A Comparative Analysis
Sustainable Financing of Innovative Therapies: A Review of Approaches
The process of innovation is inherently complex, and it occurs within an even more complex institutional environment characterized by incomplete information, market power, and externalities. There are therefore different competing approaches to supporting and financing innovation in medical technologies, which bring their own advantages and disadvantages. This article reviews value- and cost-based pricing, as well direct government funding, and cross-cutting institutional structures. It argues that performance-based risk-sharing agreements are likely to have little effect on the sustainability of financing; that there is a role for cost-based pricing models in some situations; and that the push towards longer exclusivity periods is likely contrary to the interests of industry
Differential Pricing For Pharmaceuticals: Overview Of A Widely Debated Pricing Concept And Key Challenges
PNS390 EMA/FDA PARALLEL QUALIFICATION PROCEDURE FOR THE DEVELOPMENT OF NOVEL PATIENT REPORTED OUTCOME INSTRUMENTS:PROCESS AND IMPACT
- …